LEMAITRE VASCULAR, INC. (LMAT) Shareholders’ equity 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) shareholders’ equity at each fiscal year-end, per SEC filings.
$393.5MFY2025 · since FY2016: $87.5M → $393.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $393.5M | +16.7% |
| FY2024 | $337.3M | +13.2% |
| FY2023 | $297.9M | +11.1% |
| FY2022 | $268.2M | +5.5% |
| FY2021 | $254.2M | +47.3% |
| FY2020 | $172.6M | +16.5% |
| FY2019 | $148.1M | +13.7% |
| FY2018 | $130.2M | +18.6% |
| FY2017 | $109.8M | +25.5% |
| FY2016 | $87.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice